Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus

Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for impaired glycemic control and new-onset diabetes mell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E, Silverio, Delia, Sourlas, Andreas, Garcia, Frank, Montan, Peter D, Guzman, Eliscer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267678/
https://www.ncbi.nlm.nih.gov/pubmed/30515229
http://dx.doi.org/10.7573/dic.212562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267678/
https://www.ncbi.nlm.nih.gov/pubmed/30515229
http://dx.doi.org/10.7573/dic.212562

Ejemplares similares